Notes: March 30, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and revenue cycle management solutions, today highlighted the successful continued market absorption of the Q1 2025 conversion of its Series A Preferred Stock (“Preferred A”, formerly traded as CCLDP) into common equity, while reaffirming its previously issued financial guidance and continued confidence in its growth outlook.<p> The Preferred A conversion, completed on March 6, 2025, resulted in the issuance of approximately 26 million shares of common stock, increasing CareCloud’s total common shares outstanding from approximately 16 million shares to approximately 42 million shares. Since the completion of the conversion, the Company’s stock has demonstrated resilience and continues to trade in line with levels observed prior to and during the conversion period, with a recent closing price of $3.49 on March 27, 2026. The conversion of Preferred A has been substantially completed, with only three substantial shareholders remaining. The Company believes this orderly market transition reflects the underlying strength of its business fundamentals and recurring revenue model. <P>January 21, 2025 -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, today announced that its Board of Directors (the “Board”) has decided to resume dividend payments on its Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) and Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”) earlier than previously announced based on the Company’s success at accelerating free cash flow. <p> Dec. 11, 2023 -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that its Board of Directors has suspended its monthly cash dividends for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") beginning with the payment scheduled for December 15, 2023. The suspension of these dividends will defer approximately $1.3 million in cash dividend payments each month. During this suspension, dividends will continue to accrue on the Series A and Series B Preferred Stock. The Board of Directors will regularly review and consider when the suspension should be lifted.